A new study has shed light on the potential benefits of isomaltulose, a low-glycemic carbohydrate produced by BENEO, in promoting the release of GLP-1, a hormone known for its role in weight management and glucose regulation.
The research, conducted by scientists at the University of Toronto, investigated the effects of isomaltulose consumption on GLP-1 secretion in overweight individuals. The study involved 20 participants who consumed either isomaltulose or sucrose in a randomized, double-blind, crossover trial.
The findings revealed that isomaltulose consumption led to a significantly higher increase in GLP-1 levels compared to sucrose. This effect was observed both in the early and late postprandial phases, suggesting that isomaltulose may have a prolonged impact on GLP-1 secretion.
GLP-1, short for glucagon-like peptide-1, is a hormone produced in the gut that plays a crucial role in regulating appetite, promoting satiety, and improving insulin sensitivity. Its potential to support weight management has garnered significant interest, particularly in light of the success of GLP-1 agonist medications like Ozempic, Wegovy, and Mounjaro.
While the study was conducted on a small scale, the results highlight the potential of isomaltulose as a functional ingredient that could be incorporated into food products or supplements to support weight management strategies. By naturally boosting GLP-1 levels, isomaltulose may offer a complementary approach to existing pharmacological interventions or lifestyle modifications.
As the search for effective and sustainable weight management solutions continues, this research underscores the importance of exploring the potential of functional ingredients like isomaltulose in modulating metabolic pathways and promoting overall health.
